U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07063693) titled 'Phase 1 ABY-029 Glioma Clinical Trial' on June 24.
Brief Summary: The purposes of the research trial are to study the safety of ABY-029 and to understand how much of the drug is needed to reach brain tumors so it can be visualized best by surgeons. Investigators will do this by comparing two groups of participants that receive different, very small amounts of ABY-029. Investigators will use an imaging system during surgery to record the amount of ABY-029 in the participant's tumor and in the surrounding tissue.
Study Start Date: July 31
Study Type: INTERVENTIONAL
Condition:
Intracranial Tumor
Intervention:
DRUG: ABY-029
ABY-0...